1. Home
  2. LEXX vs AMOD Comparison

LEXX vs AMOD Comparison

Compare LEXX & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • AMOD
  • Stock Information
  • Founded
  • LEXX 2004
  • AMOD 2014
  • Country
  • LEXX Canada
  • AMOD United States
  • Employees
  • LEXX N/A
  • AMOD N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • AMOD
  • Sector
  • LEXX Health Care
  • AMOD
  • Exchange
  • LEXX Nasdaq
  • AMOD NYSE
  • Market Cap
  • LEXX 19.6M
  • AMOD 18.7M
  • IPO Year
  • LEXX N/A
  • AMOD N/A
  • Fundamental
  • Price
  • LEXX $0.95
  • AMOD $1.23
  • Analyst Decision
  • LEXX Strong Buy
  • AMOD
  • Analyst Count
  • LEXX 1
  • AMOD 0
  • Target Price
  • LEXX $5.00
  • AMOD N/A
  • AVG Volume (30 Days)
  • LEXX 101.8K
  • AMOD 203.2K
  • Earning Date
  • LEXX 07-14-2025
  • AMOD 08-15-2025
  • Dividend Yield
  • LEXX N/A
  • AMOD N/A
  • EPS Growth
  • LEXX N/A
  • AMOD N/A
  • EPS
  • LEXX N/A
  • AMOD 0.12
  • Revenue
  • LEXX $615,923.00
  • AMOD N/A
  • Revenue This Year
  • LEXX $6.04
  • AMOD N/A
  • Revenue Next Year
  • LEXX $8.36
  • AMOD N/A
  • P/E Ratio
  • LEXX N/A
  • AMOD $10.86
  • Revenue Growth
  • LEXX 49.85
  • AMOD N/A
  • 52 Week Low
  • LEXX $0.79
  • AMOD $1.01
  • 52 Week High
  • LEXX $4.38
  • AMOD $13.49
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 43.10
  • AMOD N/A
  • Support Level
  • LEXX $0.79
  • AMOD N/A
  • Resistance Level
  • LEXX $0.90
  • AMOD N/A
  • Average True Range (ATR)
  • LEXX 0.04
  • AMOD 0.00
  • MACD
  • LEXX 0.01
  • AMOD 0.00
  • Stochastic Oscillator
  • LEXX 60.87
  • AMOD 0.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About AMOD ALPHA MODUS HOLDINGS INC

Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.

Share on Social Networks: